MedTrace Logo

Effects of Marijuana on Neuropathic Pain and Spasticity in Spinal Cord Injury Patients

NCT06190470 · Status: ENROLLING_BY_INVITATION · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-03-08

No results posted yet for this study

Summary

The goal of this clinical trial is to compare effects of marijuana or cannabis on neuropathic pain and spasticity in spinal cord injury patients. The main question is: Does the cannabis product from KhonKaen University reduce neuropathic pain and spasticity in spinal cord injury patients? The research design is a crossover study. The participants will be randomly into 2 groups: group 1 and group 2. The participants received either cannabis or placebo for 2 weeks. After completing treatment, participants were swapped to the other group for 2 weeks, a wash-out period is 2 weeks. The outcome measurements are pain and spasticity.

Conditions

  • Spinal Cord Injury

Interventions

DRUG

Cannabis

Cannabis product is from the extraction of the powdered, dried and mature pistillate inflorescences of Cannabis sativa L. containing THC 30mg/ml.

DRUG

Placebo

Placebo is similar to Cannabis product but do not contain THC.

Sponsors & Collaborators

  • Khon Kaen University

    lead OTHER

Principal Investigators

  • Nuttaset Manimmanakorn, MD, PhD · Rehabilitation Medicine Department, Faculty of Medicine, KhonKaen University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-02
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06190470 on ClinicalTrials.gov